Buy Shire (SHPG) on Deal Weakness, BofA/Merrill Lynch Says

Go back to Buy Shire (SHPG) on Deal Weakness, BofA/Merrill Lynch Says

SunTrust Upgrades Shire (SHPG) to Buy

October 20, 2014 8:31 AM EDT

SunTrust Robinson Humphrey upgraded Shire (NASDAQ: SHPG) from Neutral to Buy with a price target of $225.00.

For an analyst ratings summary and ratings history on Shire click here. For more ratings news on Shire click here.

Shares of Shire closed at $179.16 yesterday.

... More

AbbVie (ABBV) Board Recommends Voting Against Shire (SHPG) Transaction

October 16, 2014 6:27 AM EDT

AbbVie (NYSE: ABBV) announced its Board of Directors' withdraws its recommendation made on July 18, 2014 regarding the proposed Shire (NASDAQ: SHPG) transaction and recommends that stockholders vote against the transaction.

AbbVie and its Board of Directors made this determination following a detailed consideration of the impact of the U.S. Department of Treasury's unilateral changes to the tax rules, as issued on September 22, 2014. The breadth and scope of the changes, including the unexpected nature of the exercise of administrative authority to impact longstanding tax principles, and to target... More

Shire (SHPG) Waives 3 Day Notice for AbbVie (ABBV) Board Meeting

October 15, 2014 1:49 PM EDT

Shire (NASDAQ: SHPG) announces that, in order to allow the period of uncertainty for its shareholders, employees and other stakeholders to be reduced, it has agreed to waive the requirement for three business days' notice for AbbVie's (NYSE:... More